Back to Search Start Over

[New medications for patients with type 2 diabetes].

Authors :
Meillet L
Source :
Soins; la revue de reference infirmiere [Soins] 2014 Oct (789), pp. 15-8.
Publication Year :
2014

Abstract

Type 2 diabetes is characterised by insulin resistance and deficiencywhich explains the multitude of molecules developed for its treatment.The beneficial effects of metformin and sulfamides have been demonstrated. Over the last 10 years, new molecules have appeared: acarbose, repaglinide and incretins.

Subjects

Subjects :
Carbamates therapeutic use
Dipeptidyl-Peptidase IV Inhibitors therapeutic use
Drug Therapy, Combination
Glucagon-Like Peptide 1 agonists
Glycoside Hydrolase Inhibitors therapeutic use
Humans
Incretins therapeutic use
Piperidines therapeutic use
Diabetes Mellitus, Type 2 drug therapy
Hypoglycemic Agents therapeutic use

Details

Language :
French
ISSN :
0038-0814
Issue :
789
Database :
MEDLINE
Journal :
Soins; la revue de reference infirmiere
Publication Type :
Academic Journal
Accession number :
25518129

Tools

Authors Abstract Subjects Details